Literature DB >> 16157530

Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning.

Chao Ma1, Anren Kuang, Jiawei Xie, Tiekun Ma.   

Abstract

The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential throughout the patient's life after total or near-total thyroidectomy followed by (131)I remnant ablation and thyroid hormone suppression of thyroid-stimulating hormone (TSH). Sensitive surveillance for DTC recurrence and metastases includes radioiodine diagnostic whole-body scanning (DWBS) and measurement of serum thyroglobulin (Tg) after endogenous or exogenous TSH stimulation. Serum Tg levels during thyroid hormone withdrawal (Tg-off) are usually well correlated with the results of DWBS. In general, undetectable Tg levels with negative DWBS (DWBS(-)) suggest complete remission, whereas detectable or elevated Tg concentrations are suggestive of the presence of (131)I uptake in local or distant metastases. However, DTC patients with discordant results of Tg measurement and (131)I WBS have been observed in the follow-up study. Negative (131)I DWBS and a positive Tg test (DWBS(-) Tg(+)) are found in most of these cases. Positive (131)I DWBS and a negative Tg test (DWBS(+) Tg(-)), though of uncommon occurrence, has also been demonstrated in a small but significant number of cases. With this scenario, one should first attempt to uncover a cause for possibly false-negative or false-positive (131)I WBS or serum Tg. Explanations for the discordance are speculative but should be scrutinized when confronted with discrepant data in a given patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157530

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2015-04-28

2.  Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl's Node.

Authors:  Cory P Daignault; Edwin L Palmer; James A Scott; John S Swan; Gilbert H Daniels
Journal:  Nucl Med Mol Imaging       Date:  2015-02-03

3.  Prospective evaluation of (68)Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative (131)I-whole body scan: comparison with (18)F-FDG PET-CT.

Authors:  Parveen Kundu; Sneh Lata; Punit Sharma; Harmandeep Singh; Arun Malhotra; Chandrasekhar Bal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.

Authors:  R J D Prestwich; S Viner; G Gerrard; C N Patel; A F Scarsbrook
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

5.  Clinical analysis of a patient with a benign lesion of the pharynx misdiagnosed as functional thyroid cancer metastasis.

Authors:  Renfei Wang; Jian Tan; Guizhi Zhang; Qiang Jia
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

6.  The role of ultrasound in the follow-up of children with differentiated thyroid cancer.

Authors:  Reza Vali; Marianna Rachmiel; Jill Hamilton; Mohamad El Zein; Jonathan Wasserman; Danny L Costantini; Martin Charron; Alan Daneman
Journal:  Pediatr Radiol       Date:  2014-12-19

7.  Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of Jordan.

Authors:  Malik E Juweid; Nidal J Rabadi; Mark Tulchinsky; Mohammed Aloqaily; Ahmad Al-Momani; Majd Arabiat; Gassem Abu Ain; Hussam Al Hawari; Munther Al-Momani; Ayman Mismar; Amr Abulaban; Ibrahim Taha; Abdullah Alhouri; Ayman Zayed; Nader Albsoul; Mousa A Al-Abbadi
Journal:  Endocrine       Date:  2021-03-27       Impact factor: 3.633

8.  Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.

Authors:  Célia Lloret Linares; Didier Troisvallets; Pierre Sellier; André Aurengo; Laurence Leenhardt
Journal:  Med Oncol       Date:  2009-08-06       Impact factor: 3.064

9.  Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thyroidectomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scanning.

Authors:  Elisa Caballero-Calabuig; Carmen Cano-Terol; Ramón Sopena-Monforte; Dolores Reyes-Ojeda; Pedro Abreu-Sánchez; José Ferrer-Rebolleda; Pablo Sopena-Novales; Carmen Plancha-Mansanet; Jesús Félix-Fontestad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

10.  Clinical determinants of fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)iodine whole body scans after (131)iodine therapy.

Authors:  Syed Ejaz Shamim; Lee Boon Nang; Ibrahim Lutfi Shuaib; Nor Asiah Muhamad
Journal:  Malays J Med Sci       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.